Factors affecting immune responses to the influenza vaccine
- 6 July 2017
- journal article
- review article
- Published by Informa UK Limited in Human Vaccines & Immunotherapeutics
- Vol. 14 (3), 637-646
- https://doi.org/10.1080/21645515.2017.1338547
Abstract
Annual administration of the seasonal influenza vaccine is strongly recommended to reduce the burden of disease, particularly for persons at the highest risk for the viral infection. Even during years when there is a good match between the vaccine and circulating strains, host-related factors such as age, preexisting immunity, genetic polymorphisms, and the presence of chronic underlying conditions may compromise influenza vaccine responsiveness. The application of new methodologies and large-scale profiling technologies are improving the ability to measure vaccine immunogenicity and our understanding of the immune mechanisms by which vaccines induce protective immunity. This review attempts to summarize the general concepts of how host factors can contribute to the heterogeneity of immune responses induced by influenza vaccines.Keywords
This publication has 126 references indexed in Scilit:
- The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccinesVaccine, 2012
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2012
- Obesity is associated with impaired immune response to influenza vaccination in humansInternational Journal of Obesity, 2011
- Systems biology of vaccination for seasonal influenza in humansNature Immunology, 2011
- Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccineVaccine, 2011
- Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and OlderThe Journal of Infectious Diseases, 2009
- Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adultsVaccine, 2009
- Half- vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005)JAMA Internal Medicine, 2008
- Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled TrialThe Journal of Infectious Diseases, 2008
- In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infectionImmunology, 2007